Microvessel density as new prognostic marker after radiotherapy in rectal cancer

Abstract

BackgroundThe extent of angiogenesis is an important prognostic factor for colorectal carcinoma, however, there are few studies concerning changes in angiogenesis with radiotherapy (RTX). Our aim was to investigate changes in tumor angiogenesis influenced by radiotherapy to assess the prognostic value of angiogenesis the microvessel density (MVD) in overall survival after radiotherapy.MethodsTumor specimens were taken from 101 patients resected for rectal cancer. The patients were divided into three groups according to the treatment they received before surgery (not treated, a short course, or long course of RTX). Tumor specimens were paraffin-embedded and immunohistochemistry was performed with primary antibody against CD-34 to count MVD.ResultsMVD was significantly lower in the group of patients treated with a long course of RTX (p <0.025). The mean MVD for the long RTX group was 134.8; for the short RTX group – 192.5; and for those not treated with RTX – 193.0. There were no significant statistical correlations between MVD and age, sex, grade of tumor differentiation (G) and tumor size (T) in those untreated with RTX. In long RTX group we found a significant prognostic rate for MVD when the density cut off was near 130 with 92.3% sensitivity and 64.7% specificity. When the MVD was lower than a cut off of 130, the survival period significantly increased (p = 0.001), the mortality rate is significantly higher if the MVD is higher than 130 (microvessel/mm2) (1953.047; p = 0.002), if the histological grade is moderate/poor (127.407; p = 0.013), if the tumor is T3/T4 (111.618; p = 0.014), and if the patient is male (17.92; p = 0.034) adjusted by other variable in model.ConclusionOur results show that a long course of radiotherapy significantly decreased angiogenesis in rectal cancer tissue. MVD was found to be a favourable marker for tumor behaviour during RTX and a predictor of overall survival after long course of RTX. Further investigations are now needed to determine the changes in angiogenesis during a shorter course of RTX.

Evaluation of quality parameters of rectal cancer surgery at the Coloproctology Unit of Hospital de Braga

“…Concerning the treated patients, it was observed that males are more affected, in 57% of the cases, and that 92.4% of the cases are comprised in age groups older than 50 years, which is in accordance with literature 1,3,37 .…”

“…Colorectal cancer (CCR) is the third most common cancer and ranks the fourth position as a cause of death by cancer worldwide [1][2][3] . Its incidence is geographically varied, and there are higher rates in North America, Australia and Western Europe.…”

Thrombospondin-1 and Transforming Growth Factor-β1 Levels in Prolactinoma and their Clinical Significance

“…Angiogenesis is correlated with the development of metastasis, poor prognosis, lower survival and higher recurrence in M Jiang, CZ Mou, T Han et al TSP-1 and TGF-b 1 in prolactinoma many human tumours, including breast, bladder and stomach cancers. 5,6 Increased angiogenesis, as assessed by microvessel density, has been shown to be associated with aggressive behaviour in different tumour types, 7,8 but this relationship is less clear in pituitary tumours. Some research has found reduced microvessel density in pituitary adenomas compared with normal pituitary tissue, 9 whereas others have reported higher microvessel density in invasive pituitary adenomas compared with noninvasive tumours.…”

Isolated splenic metastasis of colon cancer: a case report and literature review

“…In Western countries, it is the second cause of death from an oncologic disease 3 . CRC is a disease that mostly affects the elderly, as only 5% of the cases are diagnosed in patients under 40 years of age 1 and, despite the improvements observed in the last decades either in surgical or new chemotherapy treatments, the CRC mortality remains high, with liver metastasis in around 50% of the patients 3 .…”

“…CRC (CRC) is the third most common neoplasm and the fourth cause of death from neoplasm worldwide 1,2 . In Western countries, it is the second cause of death from an oncologic disease 3 .…”